The Alternative Cervical Screening (ACES) team in Manchester is investigating the possibility of a urine test as an alternative to routine cervical screening. This work aims to increase screening coverage especially in communities at risk of cervical cancer but with lower rates of screening attendance, such as the LGBTQIA+ community.
Alongside members of the LGBTQIA+ community, we co-designed an online survey to explore the acceptability of self-sampling methods including urine for cervical screening. We worked closely with community members and cervical screening/LGBTQIA+ stakeholders to distribute the survey, with 503 responses, including 219 from individuals who identify as transgender.
The survey explored barriers to accessing screening and views on self-sampling options for future screening. This is the first exclusive LGBTQIA+ study in cancer prevention and early detection in Manchester and is the foundation for a pipeline of work to ensure inclusive and relevant future research for a community that is currently underserved and experiencing unique barriers to healthcare.